Meeting
2018 ASCO Annual Meeting
Significance of aromatase-estrogen receptor axis in EGFR status of lung adenocarcinoma.
Authors
Kazumi Tanaka
Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan
Kazumi Tanaka , Susumu Rokudai , Kimihiro Shimizu , Seshiru Nakazawa , Kai Obayashi , Kyoichi Kaira , Tetsunari Oyama , Ken Shirabe , Akira Mogi , Masahiko Nishiyama , Hiroyuki Kuwano
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 36, 2018 (suppl; abstr 8553)
DOI
10.1200/JCO.2018.36.15_suppl.8553
Abstract #
8553
Poster Bd #
159
Abstract Disclosures
Similar Posters
Poster
2014 ASCO Annual Meeting
Significance of the estrogen signaling pathway in EGFR wild-type lung adenocarcinoma.
First Author: Kazumi Tanaka
Poster
2018 ASCO-SITC Clinical Immuno-Oncology Symposium
Prognostic value of the expression of immunomodulatory targets in surgically resected lung adenocarcinoma.
First Author: Kazuya Takamochi
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Association of class II and III BRAF mutations with EGFR blockade therapy response and representation of molecularly distinct subgroups of BRAF mutations in MMR proficient CRC.
First Author: Ibrahim Halil Sahin
Poster
2020 ASCO Virtual Scientific Program
SRC-homology 2 domain-containing phosphatase 2 (SHP2) in epidermal growth factor receptor (EGFR)-mutant lung adenocarcinoma (LUAD).
First Author: Rafael Rosell